EUVIMEDEUVIMED entdecken
Crossref

Use of Neoadjuvant Chemotherapy in Elderly Patients With Muscle-Invasive Bladder Cancer: A Population-Based Study, 2006-2017

Natasza Posielski, Hannah Koenig, On Ho, Christopher Porter, John Paul Flores

ONCOLOGY · 2022

DOI: 10.46883/2022.25920939 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ONCOLOGY, 2022. Verfasst von Natasza Posielski und 4 weiteren Autor:innen. Beteiligte Einrichtung: Virginia Mason Hospital and Seattle Medical Center, Seattle, WA. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgedChemotherapy, AdjuvantCystectomyDatabases, FactualDisease-Free SurvivalFemaleHumansMaleMuscle NeoplasmsNeoadjuvant TherapyNeoplasm InvasivenessRetrospective StudiesTime FactorsUrinary BladderUrinary Bladder Neoplasms

Autor:innen und Institutionen

  • Virginia Mason Hospital and Seattle Medical Center, Seattle, WA.

Zitieren

APA

Posielski, N., Koenig, H., Ho, O., Porter, C., & Flores, J. P. (2022). Use of Neoadjuvant Chemotherapy in Elderly Patients With Muscle-Invasive Bladder Cancer: A Population-Based Study, 2006-2017. ONCOLOGY. https://doi.org/10.46883/2022.25920939

Vancouver

Posielski N, Koenig H, Ho O, Porter C, Flores JP. Use of Neoadjuvant Chemotherapy in Elderly Patients With Muscle-Invasive Bladder Cancer: A Population-Based Study, 2006-2017. ONCOLOGY. 2022. doi:10.46883/2022.25920939

BibTeX
@article{Posielski2022,
  author = {Posielski, Natasza and Koenig, Hannah and Ho, On and Porter, Christopher and Flores, John Paul},
  title = {Use of Neoadjuvant Chemotherapy in Elderly Patients With Muscle-Invasive Bladder Cancer: A Population-Based Study, 2006-2017},
  journal = {ONCOLOGY},
  year = {2022},
  doi = {10.46883/2022.25920939}
}
Kostenlos starten →